Gilead Sciences (GILD) PT Raised to $175 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $131.27 +4.21%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn raised the price target on Gilead Sciences (NASDAQ: GILD) to $175.00 (from $171.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Pembina Pipeline Corp. (PPL:CN) (PBA) PT Raised to Cdn$73 at CIBC
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR2,550 at BNP Paribas Exane
- EQB Inc (EQB:CN) (EQGPF) PT Raised to Cdn$151 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
